Psychiatrist

Gilda L. Sherwin, M.D.

225 Broadway, Suite 3400, New York, New York, 10007-3001

About Gilda L. Sherwin

Gilda L. Sherwin is a psychiatrist based in New York, New York who is specialized in Psychiatry. Active license number of Gilda L. Sherwin is 146111-1 for Psychiatry in New York. Her current practice location is 225 Broadway, Suite 3400, New York. Patients can contact her at 212-614-9707. Gilda L. Sherwin, M.D., specializes in Psychiatry and her NPI number (Unique professional ID assigned by NPPES) is 1710209028.

Gilda L. Sherwin specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Practice Information

Gilda L. Sherwin's specialty, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Gilda L. Sherwin
Specialization Psychiatry
Credentials M.D.
Gender Female
Practice Address: 225 Broadway, Suite 3400
New York, NY - 10007-3001

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to healthcare providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1710209028
NPI Enumeration Date: 28 Feb, 2010
NPI Last Update On: 28 Feb, 2010

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialties in the same state or different states. Related medical licenses for Gilda L. Sherwin are as mentioned below.

License NumberSpecializationStateStatus
146111-1Psychiatry New YorkPrimary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Gilda L. Sherwin
225 Broadway, Suite 3400
New York, NY - 10007-3001
Phone: 212-614-9707

Book an Appointment with Gilda L. Sherwin

To schedule an appointment, contact Gilda L. Sherwin at 225 Broadway, Suite 3400, New York, New York or call the phone number listed below.

Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Gilda L. Sherwin:

Gilda L. Sherwin is a psychiatrist specializing in Psychiatry. She specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Yes, Gilda L. Sherwin is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.
*Availability may change. Please contact the office directly to ask about appointments.

Gilda L. Sherwin practices at 225 Broadway, Suite 3400, New York, New York, 10007-3001.

To schedule an appointment with Gilda L. Sherwin, please contact the office at 212-614-9707.

Reviews & Feedback

Have you visited Gilda L. Sherwin? Share your experience to help others looking for a psychiatrist in New York, NY.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.